Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × empagliflozin × Clear all

NCT06818305 2025-12-11

EmFin-Nx

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms, Renal Insufficiency, Chronic